19
Participants
Start Date
January 29, 2021
Primary Completion Date
October 11, 2023
Study Completion Date
October 11, 2023
Carbidopa Levodopa
Patients will receive L-DOPA at doses ranging from 150 to 450 mg administered at a ratio of 1 mg carbidopa for every 4 mg L-DOPA. Starting dose is 150 mg/day with dose escalation 150 mg/day per week to a final dose of 450 mg/day
Placebo
A placebo is a sugar pill that has no therapeutic effect and will be administered orally. Participants will receive 1 placebo tablet matching the Carbidopa Levodopa tablet.
Emory University Hospital, Atlanta
National Institute of Mental Health (NIMH)
NIH
Emory University
OTHER